Medicare National Coverage Determinations (NCD) Manual (Pub. 100-03), Ch. 1 § 30.2

Thermogenic Therapy

Last amended: 2003Year: 2003Length: 158 wordsOfficial source
30.2 - Thermogenic Therapy (Rev. 1, 10-03-03) CIM 35-6 Not Covered Thermogenic therapy which is the production of artificial fever, has been in use since 1919 in the treatment of certain types of resistant infectious diseases, rheumatoid arthritis and Sydenham’s chorea. Regardless of the medium by which the fever is induced, this modality is not scientifically accepted for the treatment of any specific disease. Since the advent of potent antibiotics, the procedure has for all practical purposes been replaced as a mode of treatment. Therefore, thermogenic therapy is not considered reasonable and necessary for the treatment of an illness or injury as required by §1862(a)(1) of the Act. (Of course, where other covered services are needed and it would be reasonable and necessary that they be furnished on an inpatient hospital basis, payment would not be excluded for the inpatient stay, notwithstanding the fact that reimbursement may not be made for thermogenic therapy furnished during the hospital stay.)
Medicare National Coverage Determinations (NCD) Manual (Pub. 100-03), Ch. 1 § 30.2: Thermogenic Therapy | Justis AI